CD4 and AIDS: Persistent low CD4+ T cell levels in these patients lead to an increased incidence of AIDS and non-AIDS events, such as metabolic syndrome, cardiovascular disease, liver disease, neurocognitive impairment, and malignant tumors, which in turn increase the risk of mortality (7, 8).